Institute of Biomedical Research Corp 最近的每股收益为 $, $ 的预期。
Institute of Biomedical Research Corp MRES 上一季度的收入表现如何?
Institute of Biomedical Research Corp 上一季度的收入为 $
Institute of Biomedical Research Corp 的收入预期是多少?
根据 位华尔街分析师的预测,Institute of Biomedical Research Corp 的收入预期范围从 $ 到 $
Institute of Biomedical Research Corp 的盈利质量评分是多少?
Institute of Biomedical Research Corp 的盈利质量评分为 /。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Institute of Biomedical Research Corp 何时发布财报?
Institute of Biomedical Research Corp 的下一份财报预计在 发布
Institute of Biomedical Research Corp 的预期收益是多少?
根据华尔街分析师的预测,Institute of Biomedical Research Corp 的预期收益为 $
Institute of Biomedical Research Corp 是否超出收益预期?
Institute of Biomedical Research Corp 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0014
开盘价
$0.002
当日区间
$0.002 - $0.002
52周范围
$0.0007 - $0.0241
交易量
940.0K
平均成交量
812.7K
股息收益率
--
每股收益(TTM)
--
市值
$4.7M
什么是 MRES?
Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.